| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/5/264:05 PM | -$0.35 | -$0.13 | +62.9% | -550% | $92.7M | $102.9M | +11.0% | +24% | |
| Q2 '26 | 7/30/264:05 PM | -$0.41 | -$0.07 | ⚠ Check | -147% | $86.6M | $103.5M | +19.6% | +20% | |
| Q1 '26 | 5/6/264:05 PM | -$0.50 | -$0.49 | +2.0% | -145% | $79.7M | $83.7M | +5.0% | -5% | |
| Q4 '25 | 2/26/264:05 PM | -$0.24 | -$0.08 | +66.7% | -125% | $80.3M | $87.0M | +8.3% | +1% | |
| Q3 '25 | 11/3/254:07 PM | -$0.44 | -$0.02 | +95.5% | -125% | $71.2M | $83.0M | +16.6% | -3% | |
| Q2 '25 | 8/4/254:05 PM | -$0.50 | $0.15 | +130% | -52% | $72.4M | $86.2M | +19.0% | -1% | |
| Q1 '25 | 5/5/254:05 PM | -$0.07 | -$0.20 | -186% | -122% | $80.4M | $88.0M | +9.5% | +21% |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for).